Content Type: Research Publications

Variations in Use of Diabetes Drugs with Cardiovascular Benefits Among Medicaid Patients

March 15, 2026

Patent “Evergreening” of Medicine-Device Combination Products: A Global Perspective

March 15, 2026

Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results From a Literature Review

March 15, 2026

Experts’ Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care

March 15, 2026

Communication of Drug Efficacy Information Via a Popular Online Platform

March 15, 2026

Mifepristone, Preemption, and Public Health Federalism

March 15, 2026

Characteristics of Key Patents Covering Recent FDA-Approved Drugs:

March 15, 2026

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments

March 15, 2026

Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021

March 15, 2026

Biosimilar Competition: Early Learning

March 15, 2026

New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence

March 15, 2026

Incremental Benefits of Novel Pharmaceuticals in the UK: a Cross-Sectional Analysis of NICE Technology Appraisals From 2010 to 2020

March 15, 2026